Log in

Personalis Stock Forecast, Price & News

+0.96 (+3.80 %)
(As of 11/25/2020 12:00 AM ET)
Today's Range
Now: $26.24
50-Day Range
MA: $27.34
52-Week Range
Now: $26.24
Volume637,970 shs
Average Volume488,653 shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend YieldN/A
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Current SymbolNASDAQ:PSNL



Sales & Book Value

Annual Sales$65.21 million
Book Value$3.42 per share


Net Income$-25,080,000.00


Market Cap$1.02 billion
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable
+0.96 (+3.80 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PSNL News and Ratings via Email

Sign-up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Personalis (NASDAQ:PSNL) Frequently Asked Questions

How has Personalis' stock price been impacted by COVID-19 (Coronavirus)?

Personalis' stock was trading at $6.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PSNL stock has increased by 335.9% and is now trading at $26.24.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Personalis?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Personalis

What stocks does MarketBeat like better than Personalis?

Wall Street analysts have given Personalis a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Personalis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Personalis' next earnings date?

Personalis is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Personalis

How were Personalis' earnings last quarter?

Personalis, Inc. (NASDAQ:PSNL) issued its quarterly earnings results on Thursday, November, 5th. The company reported ($0.27) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.29) by $0.02. The company earned $19.82 million during the quarter, compared to analysts' expectations of $19.25 million. Personalis had a negative return on equity of 31.11% and a negative net margin of 43.16%.
View Personalis' earnings history

What price target have analysts set for PSNL?

7 brokers have issued 12-month target prices for Personalis' shares. Their forecasts range from $24.00 to $35.00. On average, they anticipate Personalis' share price to reach $31.14 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price.
View analysts' price targets for Personalis

Are investors shorting Personalis?

Personalis saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 1,670,000 shares, an increase of 14.4% from the October 15th total of 1,460,000 shares. Based on an average daily trading volume, of 690,300 shares, the short-interest ratio is currently 2.4 days. Currently, 7.1% of the company's stock are short sold.
View Personalis' Short Interest

Who are some of Personalis' key competitors?

What other stocks do shareholders of Personalis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and Aphria (APHA).

Who are Personalis' key executives?

Personalis' management team includes the following people:
  • Mr. John Stephen West, Co-Founder, CEO, Pres & Director (Age 63, Pay $785.44k)
  • Mr. Aaron L. Tachibana, Chief Financial Officer (Age 59, Pay $494.4k)
  • Dr. Richard Chen M.S., M.D., MS, Chief Scientific Officer (Age 49, Pay $543.75k)
  • Prof. Russ B. Altman, Co-Founder and Member of Clinical & Scientific Advisory Board
  • Mr. Euan A. Ashley M.D., Ph.D., FRCP, DPHIL, Co-Founder and Member of Clinical & Scientific Advisory Board
  • Dr. Atul Butte, Co-Founder and Member of Clinical & Scientific Advisory Board
  • Dr. Michael Snyder Ph.D., Co-Founder and Member of Clinical & Scientific Advisory Board
  • Ms. Carol J. Tillis, VP of Fin. & Admin.
  • Mr. Stephen M. Moore J.D., Gen. Counsel
  • Mr. Michael J. Fitzpatrick, VP of Worldwide Sales

When did Personalis IPO?

(PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Oppenheimer was co-manager.

What is Personalis' stock symbol?

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Who are Personalis' major shareholders?

Personalis' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Abingworth LLP (11.46%), JPMorgan Chase & Co. (9.29%), ARK Investment Management LLC (10.33%), BlackRock Inc. (6.55%), Nikko Asset Management Americas Inc. (2.89%) and Candriam Luxembourg S.C.A. (1.59%). Company insiders that own Personalis stock include Aaron Tachibana, Ken Ludlum, Lightspeed Venture Partners Se, Llp Abingworth and Richard Chen.
View institutional ownership trends for Personalis

Which major investors are selling Personalis stock?

PSNL stock was sold by a variety of institutional investors in the last quarter, including Abingworth LLP, Gabelli Funds LLC, Cadence Capital Management LLC, Candriam Luxembourg S.C.A., Los Angeles Capital Management & Equity Research Inc., and Wells Fargo & Company MN. Company insiders that have sold Personalis company stock in the last year include Aaron Tachibana, Ken Ludlum, Llp Abingworth, and Richard Chen.
View insider buying and selling activity for Personalis

Which major investors are buying Personalis stock?

PSNL stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., ARK Investment Management LLC, BlackRock Inc., Federated Hermes Inc., Nikko Asset Management Americas Inc., Voloridge Investment Management LLC, Cubist Systematic Strategies LLC, and Charles Schwab Investment Management Inc.. Company insiders that have bought Personalis stock in the last two years include Ken Ludlum, and Lightspeed Venture Partners Se.
View insider buying and selling activity for Personalis

How do I buy shares of Personalis?

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Personalis' stock price today?

One share of PSNL stock can currently be purchased for approximately $26.24.

How big of a company is Personalis?

Personalis has a market capitalization of $1.02 billion and generates $65.21 million in revenue each year. The company earns $-25,080,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis. Personalis employs 181 workers across the globe.

What is Personalis' official website?

The official website for Personalis is www.personalis.com.

How can I contact Personalis?

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.